All Dr Petra Dieterich (Senior Vice President - Abzena) articles

  • 3d,Rendered,Medically,Accurate,Illustration,Of,White,Blood,Cells,Attacking
    Article

    Why most T-cell engagers fail - and how to fix it

    2025-08-08T12:10:00Z

    Bispecific T-cell engagers are advancing fast - but complexity still slows development. This article explores how data-driven, platform-based strategies are helping overcome design and manufacturing hurdles to bring these next-gen therapies to patients faster.